$4.04
-0.46-10.22%
Last update: Sep 6, 5:15 PM
15 minutes delayed
DiaMedica Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of DiaMedica Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.13 | $-0.16 | 18.8 % |
Mar 2024 | 2024-05-08 | $-0.14 | $-0.16 | 12.5 % |
Dec 2023 | 2024-03-19 | $-0.14 | $-0.14 | 0.00 % |
Sep 2023 | 2023-11-13 | $-0.12 | $-0.13 | 7.69 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
DiaMedica Therapeutics (DMAC) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.13, which beat the estimate of $-0.16.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.